Σφακιανάκης Αλέξανδρος
ΩτοΡινοΛαρυγγολόγος
Αναπαύσεως 5 Άγιος Νικόλαος
Κρήτη 72100
00302841026182
00306932607174
alsfakia@gmail.com

Αρχειοθήκη ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader

Η λίστα ιστολογίων μου

Κυριακή 9 Απριλίου 2017

ADM guidance—Ceramics: guidance to the use of fractography in failure analysis of brittle materials

S01095641.gif

Publication date: Available online 8 April 2017
Source:Dental Materials
Author(s): Susanne S. Scherrer, Ulrich Lohbauer, Alvaro Della Bona, Alessandro Vichi, Michael J. Tholey, J. Robert Kelly, Richard van Noort, Paulo Francisco Cesar
ObjectivesTo provide background information and guidance as to how to use fractography accurately, a powerful tool for failure analysis of dental ceramic structures.MethodsAn extended palette of qualitative and quantitative fractography is provided, both for in vivo and in vitro fracture surface analyses. As visual support, this guidance document will provide micrographs of typical critical ceramic processing flaws, differentiating between pre- versus post sintering cracks, grinding damage related failures and occlusal contact wear origins and of failures due to surface degradation.ResultsThe documentation emphasizes good labeling of crack features, precise indication of the direction of crack propagation (dcp), identification of the fracture origin, the use of fractographic photomontage of critical flaws or flaw labeling on strength data graphics. A compilation of recommendations for specific applications of fractography in Dentistry is also provided.SignificanceThis guidance document will contribute to a more accurate use of fractography and help researchers to better identify, describe and understand the causes of failure, for both clinical and laboratory-scale situations. If adequately performed at a large scale, fractography will assist in optimizing the methods of processing and designing of restorative materials and components. Clinical failures may be better understood and consequently reduced by sending out the correct message regarding the fracture origin in clinical trials.



http://ift.tt/2oe4F3e

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου